Selected research
Market Structure
Global Bioconjugation Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Bioconjugation Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Bioconjugation Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Bioconjugation Service include AxisPharm, CellMosaic, Bio-Synthesis, GBI, Lonza, NJ Bio, WuXi Biologics, Creative Biolabs and Biosynth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Bioconjugation Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Bioconjugation Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Bioconjugation Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Bioconjugation Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Bioconjugation Service Segment by Company
AxisPharm
CellMosaic
Bio-Synthesis
GBI
Lonza
NJ Bio
WuXi Biologics
Creative Biolabs
Biosynth
Antibody Solutions
CheMatech
Thermo Fisher Scientific Inc
BOC Sciences
GTP Bioways
LifeSynth Solutions
iQ Biosciences
Macrocyclics
piramal pharma solutions
Bioconjugation Service Segment by Type
Protein Bioconjugation
Antibody Bioconjugation
Peptide Bioconjugation
Others
Bioconjugation Service Segment by Application
Pharmaceutical
Diagnostics
Biotechnology Research
Bioconjugation Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Bioconjugation Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Bioconjugation Service industry.
Chapter 3: Detailed analysis of Bioconjugation Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bioconjugation Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Protein Bioconjugation
- Antibody Bioconjugation
- Peptide Bioconjugation
- Others
Applications
- Pharmaceutical
- Diagnostics
- Biotechnology Research
Companies covered
- AxisPharm
- CellMosaic
- Bio-Synthesis
- GBI
- Lonza
- NJ Bio
- WuXi Biologics
- Creative Biolabs
- Biosynth
- Antibody Solutions
- CheMatech
- Thermo Fisher Scientific Inc
- BOC Sciences
- GTP Bioways
- LifeSynth Solutions
- iQ Biosciences
- Macrocyclics
- piramal pharma solutions
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Bioconjugation Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Protein Bioconjugation
- 1.2.3 Antibody Bioconjugation
- 1.2.4 Peptide Bioconjugation
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Bioconjugation Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical
- 1.3.3 Diagnostics
- 1.3.4 Biotechnology Research
- 1.4 Global Market Growth Prospects
- 1.5 Global Bioconjugation Service Growth Trends by Region
- 1.5.1 Global Bioconjugation Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Bioconjugation Service Market Size by Region (2021-2026)
- 1.5.3 Bioconjugation Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Bioconjugation Service Market Dynamics
- 2.1 Bioconjugation Service Industry Trends
- 2.2 Bioconjugation Service Industry Drivers
- 2.3 Bioconjugation Service Industry Opportunities and Challenges
- 2.4 Bioconjugation Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Bioconjugation Service Revenue by Company (2021-2026)
- 3.2 Global Bioconjugation Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Bioconjugation Service Key Company Head office and Area Served
- 3.4 Global Bioconjugation Service Company, Product Type & Application
- 3.5 Global Bioconjugation Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Bioconjugation Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Bioconjugation Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Bioconjugation Service Tier 1, Tier 2, and Tier 3
4 Bioconjugation Service Market by Type
- 4.1 Global Bioconjugation Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Bioconjugation Service Market Size by Type (2021-2032)
- 4.3 Global Bioconjugation Service Market Size Share by Type (2021-2032)
5 Bioconjugation Service Market by Application
- 5.1 Global Bioconjugation Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Bioconjugation Service Market Size by Application (2021-2032)
- 5.3 Global Bioconjugation Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 AxisPharm
- 6.1.1 AxisPharm Company Information
- 6.1.2 AxisPharm Business Overview
- 6.1.3 AxisPharm Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 AxisPharm Bioconjugation Service Product Portfolio
- 6.1.5 AxisPharm Recent Developments
- 6.2 CellMosaic
- 6.2.1 CellMosaic Company Information
- 6.2.2 CellMosaic Business Overview
- 6.2.3 CellMosaic Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 CellMosaic Bioconjugation Service Product Portfolio
- 6.2.5 CellMosaic Recent Developments
- 6.3 Bio-Synthesis
- 6.3.1 Bio-Synthesis Company Information
- 6.3.2 Bio-Synthesis Business Overview
- 6.3.3 Bio-Synthesis Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Bio-Synthesis Bioconjugation Service Product Portfolio
- 6.3.5 Bio-Synthesis Recent Developments
- 6.4 GBI
- 6.4.1 GBI Company Information
- 6.4.2 GBI Business Overview
- 6.4.3 GBI Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 GBI Bioconjugation Service Product Portfolio
- 6.4.5 GBI Recent Developments
- 6.5 Lonza
- 6.5.1 Lonza Company Information
- 6.5.2 Lonza Business Overview
- 6.5.3 Lonza Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Lonza Bioconjugation Service Product Portfolio
- 6.5.5 Lonza Recent Developments
- 6.6 NJ Bio
- 6.6.1 NJ Bio Company Information
- 6.6.2 NJ Bio Business Overview
- 6.6.3 NJ Bio Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 NJ Bio Bioconjugation Service Product Portfolio
- 6.6.5 NJ Bio Recent Developments
- 6.7 WuXi Biologics
- 6.7.1 WuXi Biologics Company Information
- 6.7.2 WuXi Biologics Business Overview
- 6.7.3 WuXi Biologics Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 WuXi Biologics Bioconjugation Service Product Portfolio
- 6.7.5 WuXi Biologics Recent Developments
- 6.8 Creative Biolabs
- 6.8.1 Creative Biolabs Company Information
- 6.8.2 Creative Biolabs Business Overview
- 6.8.3 Creative Biolabs Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Creative Biolabs Bioconjugation Service Product Portfolio
- 6.8.5 Creative Biolabs Recent Developments
- 6.9 Biosynth
- 6.9.1 Biosynth Company Information
- 6.9.2 Biosynth Business Overview
- 6.9.3 Biosynth Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Biosynth Bioconjugation Service Product Portfolio
- 6.9.5 Biosynth Recent Developments
- 6.10 Antibody Solutions
- 6.10.1 Antibody Solutions Company Information
- 6.10.2 Antibody Solutions Business Overview
- 6.10.3 Antibody Solutions Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Antibody Solutions Bioconjugation Service Product Portfolio
- 6.10.5 Antibody Solutions Recent Developments
- 6.11 CheMatech
- 6.11.1 CheMatech Company Information
- 6.11.2 CheMatech Business Overview
- 6.11.3 CheMatech Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 CheMatech Bioconjugation Service Product Portfolio
- 6.11.5 CheMatech Recent Developments
- 6.12 Thermo Fisher Scientific Inc
- 6.12.1 Thermo Fisher Scientific Inc Company Information
- 6.12.2 Thermo Fisher Scientific Inc Business Overview
- 6.12.3 Thermo Fisher Scientific Inc Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Thermo Fisher Scientific Inc Bioconjugation Service Product Portfolio
- 6.12.5 Thermo Fisher Scientific Inc Recent Developments
- 6.13 BOC Sciences
- 6.13.1 BOC Sciences Company Information
- 6.13.2 BOC Sciences Business Overview
- 6.13.3 BOC Sciences Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 BOC Sciences Bioconjugation Service Product Portfolio
- 6.13.5 BOC Sciences Recent Developments
- 6.14 GTP Bioways
- 6.14.1 GTP Bioways Company Information
- 6.14.2 GTP Bioways Business Overview
- 6.14.3 GTP Bioways Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.14.4 GTP Bioways Bioconjugation Service Product Portfolio
- 6.14.5 GTP Bioways Recent Developments
- 6.15 LifeSynth Solutions
- 6.15.1 LifeSynth Solutions Company Information
- 6.15.2 LifeSynth Solutions Business Overview
- 6.15.3 LifeSynth Solutions Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.15.4 LifeSynth Solutions Bioconjugation Service Product Portfolio
- 6.15.5 LifeSynth Solutions Recent Developments
- 6.16 iQ Biosciences
- 6.16.1 iQ Biosciences Company Information
- 6.16.2 iQ Biosciences Business Overview
- 6.16.3 iQ Biosciences Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.16.4 iQ Biosciences Bioconjugation Service Product Portfolio
- 6.16.5 iQ Biosciences Recent Developments
- 6.17 Macrocyclics
- 6.17.1 Macrocyclics Company Information
- 6.17.2 Macrocyclics Business Overview
- 6.17.3 Macrocyclics Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.17.4 Macrocyclics Bioconjugation Service Product Portfolio
- 6.17.5 Macrocyclics Recent Developments
- 6.18 piramal pharma solutions
- 6.18.1 piramal pharma solutions Company Information
- 6.18.2 piramal pharma solutions Business Overview
- 6.18.3 piramal pharma solutions Bioconjugation Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.18.4 piramal pharma solutions Bioconjugation Service Product Portfolio
- 6.18.5 piramal pharma solutions Recent Developments
7 North America
- 7.1 North America Bioconjugation Service Market Size (2021-2032)
- 7.2 North America Bioconjugation Service Market Size by Type
- 7.2.1 North America Bioconjugation Service Market Size by Type (2021-2026)
- 7.2.2 North America Bioconjugation Service Market Size by Type (2027-2032)
- 7.2.3 North America Bioconjugation Service Market Share by Type (2021-2032)
- 7.3 North America Bioconjugation Service Market Size by Application
- 7.3.1 North America Bioconjugation Service Market Size by Application (2021-2026)
- 7.3.2 North America Bioconjugation Service Market Size by Application (2027-2032)
- 7.3.3 North America Bioconjugation Service Market Share by Application (2021-2032)
- 7.4 North America Bioconjugation Service Market Size by Country
- 7.4.1 North America Bioconjugation Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Bioconjugation Service Market Size by Country (2021-2026)
- 7.4.3 North America Bioconjugation Service Market Size by Country (2027-2032)
- 7.4.4 North America Bioconjugation Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Bioconjugation Service Market Size (2021-2032)
- 8.2 Europe Bioconjugation Service Market Size by Type
- 8.2.1 Europe Bioconjugation Service Market Size by Type (2021-2026)
- 8.2.2 Europe Bioconjugation Service Market Size by Type (2027-2032)
- 8.2.3 Europe Bioconjugation Service Market Share by Type (2021-2032)
- 8.3 Europe Bioconjugation Service Market Size by Application
- 8.3.1 Europe Bioconjugation Service Market Size by Application (2021-2026)
- 8.3.2 Europe Bioconjugation Service Market Size by Application (2027-2032)
- 8.3.3 Europe Bioconjugation Service Market Share by Application (2021-2032)
- 8.4 Europe Bioconjugation Service Market Size by Country
- 8.4.1 Europe Bioconjugation Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Bioconjugation Service Market Size by Country (2021-2026)
- 8.4.3 Europe Bioconjugation Service Market Size by Country (2027-2032)
- 8.4.4 Europe Bioconjugation Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Bioconjugation Service Market Size (2021-2032)
- 9.2 China Bioconjugation Service Market Size by Type
- 9.2.1 China Bioconjugation Service Market Size by Type (2021-2026)
- 9.2.2 China Bioconjugation Service Market Size by Type (2027-2032)
- 9.2.3 China Bioconjugation Service Market Share by Type (2021-2032)
- 9.3 China Bioconjugation Service Market Size by Application
- 9.3.1 China Bioconjugation Service Market Size by Application (2021-2026)
- 9.3.2 China Bioconjugation Service Market Size by Application (2027-2032)
- 9.3.3 China Bioconjugation Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Bioconjugation Service Market Size (2021-2032)
- 10.2 Asia Bioconjugation Service Market Size by Type
- 10.2.1 Asia Bioconjugation Service Market Size by Type (2021-2026)
- 10.2.2 Asia Bioconjugation Service Market Size by Type (2027-2032)
- 10.2.3 Asia Bioconjugation Service Market Share by Type (2021-2032)
- 10.3 Asia Bioconjugation Service Market Size by Application
- 10.3.1 Asia Bioconjugation Service Market Size by Application (2021-2026)
- 10.3.2 Asia Bioconjugation Service Market Size by Application (2027-2032)
- 10.3.3 Asia Bioconjugation Service Market Share by Application (2021-2032)
- 10.4 Asia Bioconjugation Service Market Size by Country
- 10.4.1 Asia Bioconjugation Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Bioconjugation Service Market Size by Country (2021-2026)
- 10.4.3 Asia Bioconjugation Service Market Size by Country (2027-2032)
- 10.4.4 Asia Bioconjugation Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Bioconjugation Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Bioconjugation Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Bioconjugation Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Bioconjugation Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Bioconjugation Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Bioconjugation Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Bioconjugation Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Bioconjugation Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Bioconjugation Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Bioconjugation Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Bioconjugation Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Bioconjugation Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Bioconjugation Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Bioconjugation Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst